Dear Doctor - Participate in the Survey on psoriatic arthritis " A new survey has found that psoriatic arthritis can have a significant impact on patients' quality of life. The study, which was conducted by the National Psoriasis Foundation (NPF), surveyed more than 3,500 people with psoriatic arthritis and found that the condition can severely affect patients physically, emotionally, and socially.The NPF survey found that psoriatic arthritis can cause pain, fatigue, stiffness, joint damage, and disability. The condition can also lead to depression and anxiety. In addition, the survey found that people with psoriatic arthritis are often socially isolated and have difficulty keeping up with work and daily activities."This survey provides new insights into the real-world impact of psoriatic arthritis," said NPF President Andrew Prince. "It's important for people with psoriatic arthritis to know they are not alone. There are a wide variety of resources available to help manage this complex disease." Participate in Surveys "
1.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
2.
Transplantation Fails to Improve Survival in Mantle Cell Lymphoma
3.
In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.
4.
PSMA PET Beats MRI in Prostate Cancer Staging Study
5.
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor
1.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
2.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
3.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
4.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
5.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Navigating the Complexities of Ph Negative ALL - Part VIII
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation